Literature DB >> 1945548

Clinical assessment of emotional milestones in infancy and early childhood.

S I Greenspan1.   

Abstract

It is now possible to monitor, assess, and, where necessary, facilitate emotional development in infants, young children, and their families. The focus on the infant and the family from multiple aspects of development has made it possible to formulate developmental stages that focus on the infant's social and emotional functioning. This article includes an outline for the emotional evaluation of infants and young children.

Entities:  

Mesh：

Year:  1991        PMID： 1945548     DOI： 10.1016/s0031-3955(16)38225-6

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  2 in total

1.  One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development.

Authors:  Anne M Connolly; Julaine M Florence; Mary M Cradock; Michelle Eagle; Kevin M Flanigan; Craig M McDonald; Peter I Karachunski; Basil T Darras; Kate Bushby; Elizabeth C Malkus; Paul T Golumbek; Craig M Zaidman; J Philip Miller; Jerry R Mendell
Journal:  Pediatr Neurol       Date:  2014-02-15       Impact factor: 3.372

2.  Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.

Authors:  Anne M Connolly; Julaine M Florence; Mary M Cradock; Elizabeth C Malkus; Jeanine R Schierbecker; Catherine A Siener; Charlie O Wulf; Pallavi Anand; Paul T Golumbek; Craig M Zaidman; J Philip Miller; Linda P Lowes; Lindsay N Alfano; Laurence Viollet-Callendret; Kevin M Flanigan; Jerry R Mendell; Craig M McDonald; Erica Goude; Linda Johnson; Alina Nicorici; Peter I Karachunski; John W Day; Joline C Dalton; Janey M Farber; Karen K Buser; Basil T Darras; Peter B Kang; Susan O Riley; Elizabeth Shriber; Rebecca Parad; Kate Bushby; Michelle Eagle
Journal:  Neuromuscul Disord       Date:  2013-05-28       Impact factor: 4.296
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.